Isis Pharmaceuticals ISIS
-
3 Biotech Stocks On The Move
… the movement toward personalized medicine have made this speculative stock a buy on some analysts' lists. Isis Pharmaceuticals ( ISIS ) shares have broken above the barrier of Complete Story »
-
Isis Pharmaceuticals' Management Presents at Bank of America Merrill Lynch 2012 Health Care Conference (Transcript)
Isis Pharmaceuticals , Inc. ( ISIS ) Bank of America Merrill Lynch 2012 Health Care Conference ..... m happy to be here this afternoon and talk to you about Isis Pharmaceuticals . It’s a very exciting year we have in front of us. This …
-
Isis : A Pick To Win The Biotech Derby
… of a stretch. So in the race for biotech success, which is the company with the best combination for my wager? Isis ( ISIS ). Isis has had its share of promise unrealized in its history, dropping from its $20 share price days. Yet to get a …
-
Isis Pharmaceuticals' CEO Discusses Q1 2012 Results - Earnings Call Transcript
Isis Pharmaceuticals , Inc. ( ISIS ) Q1 2012 Earnings Conference Call May 8, 2012 16:30 ET Executives ..... Stephen Willey – Stifel Nicolaus Presentation Operator Welcome to the ISIS Pharmaceutical's First Quarter Financial Results Conference Call …
-
ISIS Pharmaceuticals ( ISIS ): Q1 EPS of -$0.24 beats by $0.04. Revenue of $23.2M (+10% Y/Y) beats by $1M. (PR)
ISIS Pharmaceuticals ( ISIS ): Q1 EPS of -$0.24 beats by $0.04 . Revenue of $23.2M (+10% Y/Y) beats by $1M . ( PR ) Post your comment!
-
Top March 2012 Quarter Picks From $1 Billion Pure-Play Biotech Swiss Hedge Fund BB Biotech
By Ganaxi Small Cap Movers : Switzerland-based BB Biotech, founded in 1993, is one of the largest pure-play biotech investment companies, and also a public company with its shares are listed on the Swiss Stock Market. About a third of its assets are invested in oncology-focused biotech companies,
-
Isis Pharmaceuticals' CEO Discusses Clinical Development Plans for ISIS -APOCIIIRx (Transcript)
Isis Pharmaceuticals , Inc. ( ISIS ) Clinical Development Plans for ISIS -APOCIIIRx Call May ..... Presentation Good day ladies and gentlemen and welcome to Isis Pharmaceuticals ' apoC-III conference call. Leading the call today from …
-
Biotechnology And Drugs Stocks To Watch Next Week
By StockPandit : Next week is a busy earnings season, with many quarterly earnings releases scheduled and a bunch of stocks to watch. However, my focus is on biotechnology and drugs stocks that have earnings due in the next week. This article provides earnings previews on several stocks to consider
-
2 Biotech Stocks That Could Jump On Hepatitis C Breakthroughs
By Ry Frank : I believe the best investments in the biotech market are in companies focused on the treatment of chronic diseases. There are many people suffering from diseases for which there are no cures, but medical science has developed ways to manage these illnesses and make it possible to live
-
Abbott's Game-Changing PLEX-ID Receives CE Mark
… sold in Europe and several other countries. The PLEX-ID was originally called the Ibis and was owned by Isis Pharmaceuticals . Isis ( ISIS ) had some initial success with the device while it was in a research stage working with the US military …